Amlodipine and Olmesartan Medoxomil (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Amlodipine and Olmesartan Medoxomil drug offered from Glenmark Pharmaceuticals Inc., USA. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Amlodipine and Olmesartan Medoxomil |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-07-05 |
| END MARKETING DATE: | 0000-00-00 |
Amlodipine and Olmesartan Medoxomil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amlodipine and Olmesartan Medoxomil from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2017-07-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-566_0151a4f5-40ec-4054-8487-8327b23841cb |
| PRODUCT NDC: | 68462-566 |
| APPLICATION NUMBER: | ANDA207807 |
Other AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers:
